Getinge said Tuesday it will phase out its surgical perfusion business and reallocate resources to higher-growth areas such as extracorporeal membrane oxygenation (ECMO) and transplant care. CEO ...

GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S. (Reuters) ...

Narrow-moat Getinge GETI B reported third-quarter earnings above our expectations. We are increasing our fair value estimate to SEK 247 from SEK 221, as Getinge is executing a turnaround in its acute ...

GÖTEBORG, Sweden, July 24, 2020 /PRNewswire/ -- Today Getinge announces its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and ...

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and ...

Getinge’s GETI B recent litany of regulatory, quality, and supply chain troubles across multiple products provides us with a flashback to 2013-2015 when similar issues culminated in a consent decree ...

Price hikes and cost saving measures aid Getinge's earnings growth Absorbs chunk of near-term tariff costs before pricing measures fully bite US probe into medtech imports doesn't affect Getinge, CEO ...

Getinge, a Swedish public limited company, announced on September 11, 2024 that it completed acquisition of Paragonix Technologies, Inc., a U.S. company specializing in organ transport products and ...

* GETINGE CEO: NORMALISATION IN CHINA IS SLOWLY BUT SURELY HAPPENING AFTER COVID BUT WE DON'T SEE A STRONG RECOVERY OR STRONG POSITIVE IMPACT YET * GETINGE CEO: WE EXPECT MIXED PERFORMANCE FROM CHINA ...

Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Getinge on June 12 and set a price target of SEK260.00. The company’s shares closed last Friday at SEK196.25. C ...